Dr Reddy’s, Hetero to sell generic HIV prevention drug for $40 a year

Lenacapavir, developed by Gilead Sciences and approved earlier this year for HIV prevention under the brand name Yeztugo, is a twice-yearly injection that was nearly 100% effective at preventing HIV in large trials.

Published: September 24, 2025 5:48 pm

Source: CNBC TV18 — Read original